XML 55 R14.htm IDEA: XBRL DOCUMENT v3.20.1
STOCK-BASED COMPENSATION
 12 Months Ended
Mar. 28, 2020
Share-based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION

NOTE 6 – STOCK-BASED COMPENSATION

The Company has a share-based incentive plan (the “2003 Plan”) that provides for, among other awards, grants of restricted stock units and stock options to directors, officers and key employees at the fair market value at the date of grant. At March 28, 2020, 1.0 million restricted stock units or stock options were available for future grant under the 2003 Plan.

The Company receives an excess tax benefit related to restricted stock vesting and stock options exercised and redeemed. The discrete benefits related to share-based compensation awards in fiscal years 2020 and 2019 were $0.9 million and $0.1 million, respectively.

Restricted Stock: The Company grants time-based and performance-based restricted stock units as a component of executive and key employee compensation. Expense for restricted stock grants is recognized on a straight-line basis for the service period of the stock award based upon fair value of the award on the date of grant. The fair value of the restricted stock grants is the quoted market price for the Company’s common stock on the date of grant. These restricted stock units are either time vested or vest following the third fiscal year from the date of grant subject to cumulative diluted earnings per share targets over the eligible period.

Beginning in fiscal year 2020, the annual performance-based award for the Company’s non-employee directors was replaced with an annual grant of restricted stock units valued at $50,000 that vest after one year. The restricted stock unit grants to non-employee directors were made in September 2019.

Compensation cost ultimately recognized for performance-based restricted stock units will equal the grant date fair market value of the number of units that coincides with the actual outcome of the performance conditions. On an interim basis, the Company records compensation cost based on the estimated level of achievement of the performance conditions. The expense relating to the time vested restricted stock units is recognized on a straight-line basis over the requisite service period for the entire award.

During fiscal year 2020, 47,000 shares granted were time vested and 28,000 shares were subject to performance targets. During fiscal year 2019, 42,000 shares granted were time vested and 30,000 shares were subject to performance targets.

The following table summarizes the restricted stock units vested and shares issued during fiscal years 2020 and 2019 (amounts in thousands):

Grant
Total Date Number
Number Fair Target Of Date
Date Measurement of Units Value Level Shares Shares
Granted Period Granted Per Unit Achieved Issued Issued
April 2015       April 2015 – March 2018       63       $      9.59       50%       32       May 2018
June 2017 June 2017 – May 2018 1 $ 12.00 Time Vested 1 June 2018
January 2019 January 2019 1 $ 19.04 Time Vested 1 January 2019
April 2018 April 2018 – March 2019 1 $ 15.65 Time Vested 1 April 2019
April 2016 April 2016 – March 2019 82 $ 10.13 131% 107 May 2019
June 2017 June 2017 – May 2019 1 $ 12.00 Time Vested 1 June 2019
October 2018 October 2018 – September 2019 1 $ 20.81 Time Vested 1 October 2019

The following table summarizes the non-vested restricted stock units outstanding as of March 28, 2020:

Total Grant Date Estimated
Number Fair Level of
Date Measurement of Units Value Achievement at
Granted Period Granted Per Unit March 28, 2020
April 2017       April 2017 – March 2020       62       $      12.90       79% of target level
April 2018 April 2018 – March 2020 1 $ 15.65 Time Vested
May 2018 April 2018 – March 2021 23 $ 15.30 90% of target level
May 2018 April 2018 – March 2021 24 $ 15.30 Time Vested
October 2018 October 2018 – September 2027 9 $ 20.81 Time Vested
May 2019 April 2019 – March 2022 24 $ 23.50 90% of target level
May 2019 April 2019 – March 2022 24 $ 23.50 Time Vested
August 2019 August 2019 – July 2020 1 $ 23.00 Time Vested
September 2019 September 2019 – September 2020 18 $ 22.77 Time Vested

Total expense relating to restricted stock units, based on grant date fair value and the achievement criteria, was $0.8 million and $1.1 million in fiscal years 2020 and 2019, respectively. Unearned compensation totaled $1.3 million as of March 28, 2020.

Stock Options: The Company grants stock options to employees and directors equal to the quoted market price of the Company’s stock at the date of the grant. The fair value of stock options is estimated using the Black-Scholes option pricing formula that requires assumptions for expected volatility, expected dividends, the risk-free interest rate and the expected term of the option. Expense for stock options is recognized on a straight-lined basis over the requisite service period for each award. Options vest either immediately or over a period of up to five years using a straight-line basis and expire either five years or ten years from the date of grant.

During fiscal year 2020, the Company’s Board of Directors granted an option for 5,000 shares of common stock to a Company employee that vest over three years, and an option for 10,000 shares of common stock to a new member of the Board of Directors that vest over 5 years. During fiscal year 2019, the Company’s Board of Directors granted stock options for 25,000 shares of common stock to Company employees. 5,000 shares pursuant to these options immediately vested. 20,000 shares pursuant to these options vest over five years. The expense related to all stock option awards was $0.1 million in each of fiscal year 2020 and 2019.

The following table summarizes the Company’s options for fiscal years 2020 and 2019:

Weighted Weighted
Average Average
Number Exercise Remaining Aggregate
Of Price Per Contractual Intrinsic
Shares Share Term (in Years) Value
Outstanding as of March 31, 2018       272       $      10.27            
Granted 25 19.95
Exercised (2 ) 9.66
Forfeited (4 ) 6.75
Outstanding as of March 30, 2019 291 11.16
Granted 15 25.06
Exercised       (156 ) 9.16
Forfeited - -
Outstanding as of March 28, 2020 150 14.63 4 $      1,619
Exercisable as of March 28, 2020 115 $ 12.20 3 $ 1,514

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of fiscal year 2020 and the exercise price, multiplied by the number of in-the-money stock options) that would have been received by the option holders had all holders exercised their options on March 28, 2020. The amount of aggregate intrinsic value will change based on the fair market value of the Company’s stock.

Total unrecognized compensation cost related to non-vested stock options as of March 28, 2020 was $0.2 million, which is expected to be recognized over a period of five years. The aggregate intrinsic value of stock options exercised in fiscal years 2020 and 2019 was $2.5 million and less than $0.1 million, respectively. Cash received from the exercise of options in fiscal years 2020 and 2019 was $1.4 million and less than $0.1 million, respectively.